1Carrafiello G, Lagana D, Mangini M, et al. Microwave tumors ablation.. Principles clinical applications and review of prelimi- nary experiences[J]. Int J surg,2008,6:65 -69.
5Karnofsky DA. Meaningful clinical classification of therapeutic responses to anticancer drugs [ J]. Clin Pharmacol Ther, 1961,2: 709-712.
6Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment[ J ]. Cancer, 1981,47 ( 1 ) :207-214.
7Therasse P, Arbuck SG, Eisenhauer EA,et al. New guidelines to evaluate the response to treatment in solid tumors[ J]. J Natl Cancer Inst,2000,92(3) :179-181.
8Mazumdar M, Smith A, Schwartz LH. A statistical simulation study finds discordance between WHO criteria and RECIST guideline [ J]. J Clin Epidemio1,2004,57 (4) :358-365.
9van Klaveren RJ, Aerts JG, de Bruin H, et al. Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma[ J ]. Lung Cancer,2004,43 ( 1 ) :63-69.
10Tropine A, Dellani PD, Glaser M ,et al. Differentiation of fibroblastic meningiomas from other benign subtypes using diffusion tensor imaging[J]. J Magn Reson Imaging,2007,25(4) :703-708.
